• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有缺失A环侧链取代基和可变C-2'构型的生物活性紫杉醇类似物。

Biologically active taxol analogues with deleted A-ring side chain substituents and variable C-2' configurations.

作者信息

Swindell C S, Krauss N E, Horwitz S B, Ringel I

机构信息

Department of Chemistry, Bryn Mawr College, Pennsylvania 19010.

出版信息

J Med Chem. 1991 Mar;34(3):1176-84. doi: 10.1021/jm00107a042.

DOI:10.1021/jm00107a042
PMID:1672157
Abstract

Taxol, a potent inhibitor of cell replication, enhances the assembly of tubulin into stable microtubules and promotes the formation of microtubule bundles in cells. In addition to its unique mechanism of action, taxol exhibits unusual promise as an antitumor agent, but its application in cancer chemotherapy is hampered by its limited availability. In order to better define the structure-activity profile of taxol for the design of more accessible drugs and to provide insight into the chemical features of the taxol-microtubule interaction, taxol analogues 3-8, with deleted A-ring side chain substituents and both R and S C-2' configurations, were synthesized from baccatin III through esterification at the hindered 13-hydroxyl. Employing an improved hydroxyl protection strategy, lactate analogues 3 and 4 were prepared with reasonable efficiency owing to their simple side-chain structures, while N-benzoylisoserine analogues 7 and 8 were synthesized through esterification reactions whose rates were enhanced greatly by the participation of the amide functionality. Although less biologically active than taxol, analogues 5-7 were found to promote the polymerization of tubulin and to be cytotoxic; 5 and 6 were considerably more effective than 7, whereas 3, 4, and 8 were least active. Interestingly, tubulin polymerization was sensitive to the C-2' configuration only when the amide substituent was present in the side chain. This observation suggests that the 3'-amide substituent plays an important role in preorganizing the taxol side chain to bind to microtubules.

摘要

紫杉醇是一种有效的细胞复制抑制剂,可增强微管蛋白组装成稳定的微管,并促进细胞中微管束的形成。除了其独特的作用机制外,紫杉醇作为一种抗肿瘤药物还展现出非凡的前景,但其在癌症化疗中的应用因供应有限而受到阻碍。为了更好地确定紫杉醇的构效关系,以设计出更易获取的药物,并深入了解紫杉醇与微管相互作用的化学特征,从巴卡亭III出发,通过对受阻的13-羟基进行酯化反应,合成了A环侧链取代基缺失且具有R和S两种C-2'构型的紫杉醇类似物3 - 8。采用改进的羟基保护策略,由于乳酸类似物3和4的侧链结构简单,因此能以合理的效率制备得到;而N-苯甲酰异丝氨酸类似物7和8则通过酯化反应合成,酰胺官能团的参与极大地提高了反应速率。尽管类似物5 - 7的生物活性低于紫杉醇,但它们能促进微管蛋白的聚合且具有细胞毒性;5和6的效果明显优于7,而3、4和8的活性最低。有趣的是,只有当侧链中存在酰胺取代基时,微管蛋白聚合才对C-2'构型敏感。这一观察结果表明,3'-酰胺取代基在使紫杉醇侧链预组织以结合微管方面起着重要作用。

相似文献

1
Biologically active taxol analogues with deleted A-ring side chain substituents and variable C-2' configurations.具有缺失A环侧链取代基和可变C-2'构型的生物活性紫杉醇类似物。
J Med Chem. 1991 Mar;34(3):1176-84. doi: 10.1021/jm00107a042.
2
Relationships between the structure of taxol analogues and their antimitotic activity.
J Med Chem. 1991 Mar;34(3):992-8. doi: 10.1021/jm00107a017.
3
Baccatin III induces assembly of purified tubulin into long microtubules.浆果赤霉素III诱导纯化的微管蛋白组装成长微管。
Biochemistry. 2001 Jun 12;40(23):6964-70. doi: 10.1021/bi002816i.
4
Characterization of two taxol photoaffinity analogues bearing azide and benzophenone-related photoreactive substituents in the A-ring side chain.A环侧链上带有叠氮化物和二苯甲酮相关光反应性取代基的两种紫杉醇光亲和类似物的表征。
J Med Chem. 1994 May 13;37(10):1446-9. doi: 10.1021/jm00036a009.
5
Studies with RP 56976 (taxotere): a semisynthetic analogue of taxol.
J Natl Cancer Inst. 1991 Feb 20;83(4):288-91. doi: 10.1093/jnci/83.4.288.
6
Synthesis of biologically active taxol analogues with modified phenylisoserine side chains.具有修饰苯异丝氨酸侧链的生物活性紫杉醇类似物的合成。
J Med Chem. 1992 Oct 30;35(22):4230-7. doi: 10.1021/jm00100a031.
7
Discodermolide, a cytotoxic marine agent that stabilizes microtubules more potently than taxol.软海绵素,一种细胞毒性海洋药物,其稳定微管的能力比紫杉醇更强。
Biochemistry. 1996 Jan 9;35(1):243-50. doi: 10.1021/bi9515127.
8
Synthesis and evaluation of some water-soluble prodrugs and derivatives of taxol with antitumor activity.一些具有抗肿瘤活性的紫杉醇水溶性前药及其衍生物的合成与评价。
J Med Chem. 1992 Jan;35(1):145-51. doi: 10.1021/jm00079a019.
9
Interaction of C-9 aldehydes with microtubular protein in vitro and in cultured cells in the presence of taxol.在紫杉醇存在的情况下,C-9醛与微管蛋白在体外及培养细胞中的相互作用。
Res Commun Chem Pathol Pharmacol. 1991 Aug;73(2):131-44.
10
Direct photoaffinity labeling of tubulin with taxol.用紫杉醇对微管蛋白进行直接光亲和标记。
J Natl Cancer Inst. 1992 May 20;84(10):785-8. doi: 10.1093/jnci/84.10.785.

引用本文的文献

1
Taking paclitaxel coated balloons to a higher level: Predicting coating dissolution kinetics, tissue retention and dosing dynamics.将紫杉醇涂层球囊提升到一个新的水平:预测涂层溶解动力学、组织保留和给药动力学。
J Control Release. 2019 Sep 28;310:94-102. doi: 10.1016/j.jconrel.2019.08.019. Epub 2019 Aug 17.
2
Prevention of paclitaxel-induced neuropathy by formulation approach.通过配方方法预防紫杉醇诱导的周围神经病。
J Control Release. 2019 Jun 10;303:109-116. doi: 10.1016/j.jconrel.2019.04.013. Epub 2019 Apr 11.
3
Physiologically-based modeling and interspecies prediction of paclitaxel pharmacokinetics.
基于生理学的紫杉醇药代动力学模型构建和种属间预测。
J Pharmacokinet Pharmacodyn. 2018 Aug;45(4):577-592. doi: 10.1007/s10928-018-9586-9. Epub 2018 Apr 18.
4
Nanoparticles Containing High Loads of Paclitaxel-Silicate Prodrugs: Formulation, Drug Release, and Anticancer Efficacy.负载高剂量紫杉醇 - 硅酸盐前药的纳米颗粒:制剂、药物释放及抗癌疗效
Mol Pharm. 2015 Dec 7;12(12):4329-35. doi: 10.1021/acs.molpharmaceut.5b00530. Epub 2015 Nov 4.
5
Development of paclitaxel-TyroSpheres for topical skin treatment.紫杉醇-TyroSpheres 的开发用于局部皮肤治疗。
J Control Release. 2012 Oct 10;163(1):18-24. doi: 10.1016/j.jconrel.2012.06.021. Epub 2012 Jun 23.
6
Recent advances in the study of the bioactive conformation of taxol.紫杉醇生物活性构象研究的最新进展。
ChemMedChem. 2009 May;4(5):719-31. doi: 10.1002/cmdc.200900044.
7
Development of new lipid-based paclitaxel nanoparticles using sequential simplex optimization.采用序贯单纯形优化法开发新型脂质基紫杉醇纳米粒。
Eur J Pharm Biopharm. 2009 May;72(1):9-17. doi: 10.1016/j.ejpb.2008.11.012. Epub 2008 Dec 10.
8
Intracellular drug delivery by poly(lactic-co-glycolic acid) nanoparticles, revisited.聚乳酸-乙醇酸共聚物纳米颗粒介导的细胞内药物递送研究新进展
Mol Pharm. 2009 Jan-Feb;6(1):190-201. doi: 10.1021/mp800137z.
9
Understanding tubulin-Taxol interactions: mutations that impart Taxol binding to yeast tubulin.了解微管蛋白与紫杉醇的相互作用:赋予酵母微管蛋白紫杉醇结合能力的突变。
Proc Natl Acad Sci U S A. 2003 May 27;100(11):6394-7. doi: 10.1073/pnas.1131967100. Epub 2003 May 9.
10
The binding conformation of Taxol in beta-tubulin: a model based on electron crystallographic density.紫杉醇在β-微管蛋白中的结合构象:基于电子晶体学密度的模型
Proc Natl Acad Sci U S A. 2001 Apr 24;98(9):5312-6. doi: 10.1073/pnas.051309398. Epub 2001 Apr 17.